Blood Pressure Clinical Trial
Official title:
The Effects of the Onion-Pumpkin Extract on Blood Pressure: An Open-label, Adaptive-design, Pilot Study
This open-label, adaptive-design, pilot study was designed to evaluate the effect of Onion-Pumpkin Extract in supporting healthy blood pressure as assessed by the change in systolic and diastolic blood pressures. The effect of the product on glucose metabolism, lipid levels, and antioxidant levels would also be determined. Tolerability and safety of the study product would also be investigated.
Hypertension has become one of the most common diseases in the world and considered a public
health challenge due to its association with morbidity and mortality and increased cost to
society. Hypertension is the most important risk factor for cardiovascular diseases such as
coronary heart disease, stroke, congestive heart failure, and peripheral vascular disease.
One fourth of adults in the United States have high blood pressure and among these, the
blacks and the elderly have higher incidence of hypertension. This condition is
characterized by abnormally high blood pressure with the systolic greater than 140 mmHg and
diastolic greater than 90 mmHg (1).
Lowering blood pressure has been linked to 35% to 40% reductions in the incidence of stroke,
20%-25% in myocardial infarction, and 50% in heart failure. Management of hypertension
includes lifestyle modifications and pharmacological therapy and antihypertensive drugs.
Lifestyle modifications such as weight reduction in overweight and obese individuals, 8-week
diet of fruits, vegetables, low-fat dairy products, whole grain, poultry fish and nuts with
limited fats, red meat and sweets, reduction in dietary sodium, physical activity, and
moderation of alcohol consumption have been shown to lower blood pressure. There are several
classes of antihypertensive drugs, including angiotensin converting enzyme (ACE) inhibitors,
angiotensin receptor blockers (ARBs) β-blockers (BBs), calcium channel blockers (CCBs) and
the thiazide-class diuretics. Among these, the diuretic based therapy was more effective
than other treatments in preventing cardiovascular diseases as demonstrated by the
Antihypertensive and Lipid-lowering Treatment to prevent Heart Attack (ALLHAT) trial (1, 2).
Blood pressure can be lowered without using prescription drugs. Nutraceuticals have found
their application in the treatment of hypertension. Omega-3 polyunsaturated fatty acids,
omega-9 fatty acids, garlic, seaweed, and various vitamins and minerals have been shown to
reduce blood pressure significantly (3).
Animal studies have demonstrated the potential benefits of onion in hypertensive rats. In
one study involving rats fed with a control diet or a high-fat high-sucrose diet with or
without Welsh onion for 4 weeks, lower blood pressure was observed in rats with onion diet,
especially the green-leafy type. In addition, these rats have higher levels of nitric oxide
(NO) metabolites in the urine and plasma, lower activity of NADH/NADPH oxidase in the aorta,
and suppressed angiotensin II production (4). The mechanism of the antihypertensive effect
of onion probably involves increased saving of NO (4, 5). A randomized, placebo-controlled,
double-blind trial also demonstrated significant decrease in arterial blood pressure and
reduction in plasma viscosity five hours after administration of a formulation containing
onion and olive oil (6).
Pumpkin has been used as a traditional medicine and it is known for its antidiabetic,
antitumor, antibacterial, anti-inflammatory, and antihypertensive properties (7). Animal
studies confirmed that pumpkin seed oil supplementation resulted in lower systolic and
diastolic blood pressure as well as improvements in lipid profile in both non-ovariectomized
and ovariectomized rats (8). Using enzyme assays, it was demonstrated that pumpkin have
moderate to high alpha-glucosidase and ACE inhibitory activities (9). A recent clinical
trial involved postmenopausal women and the effects of supplemented pumpkin seed oil in
cholesterol levels. The results of this trial showed that 12-week administration of 2g/day
pumpkin seed oil led to a significant increase in HDL cholesterol and significant decrease
in diastolic blood pressure. Pumpkin seed oil also improved menopausal symptom scores by
decreasing hot flushes, headaches, and joint pains (10).
This open-label, adaptive-design, pilot study was designed to evaluate the effect of
Onion-Pumpkin Extract in supporting healthy blood pressure as assessed by the change in
systolic and diastolic blood pressures. The effect of the product on glucose metabolism,
lipid levels, and antioxidant levels would also be determined. Tolerability and safety of
the study product would also be investigated.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT05997303 -
Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT03918486 -
Caretaker vs. Routine Blood Pressure Sphygmomanometer
|
||
Completed |
NCT03410342 -
The Effects of Types of Fruits and Vegetables on Vascular Function
|
N/A | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT04087070 -
Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
|
||
Completed |
NCT03294928 -
Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers
|
N/A | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03997461 -
Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device
|
N/A | |
Completed |
NCT03290716 -
Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China
|
N/A | |
Recruiting |
NCT06460233 -
Blood Pressure Changes After Bariatric Surgery
|
||
Recruiting |
NCT05196048 -
Blood Pressure Sensor of Watch-type Device With ECG Technology
|
||
Terminated |
NCT03325933 -
Resistance Training and Cardiometabolic Health
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Completed |
NCT02924454 -
Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
|
Phase 4 | |
Completed |
NCT02451059 -
Reducing Socioeconomic Disparities in Health at Pediatric Visits
|
N/A | |
Active, not recruiting |
NCT02670967 -
Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials
|
N/A | |
Completed |
NCT02239744 -
Intervention Study on the Health Impact of Air Filters in Chinese Adults
|
N/A | |
Completed |
NCT02271633 -
Nitrate Supplementation; Source
|
Phase 4 |